These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 29239011)

  • 1. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster.
    Miyachi M; Ihara H; Imafuku S
    J Dermatol; 2017 Jun; 44(6):656-659. PubMed ID: 28012212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunoglobulins M and G to varicella-zoster virus measured by solid-phase radioimmunoassay: antibody responses to varicella and herpes zoster infections.
    Arvin AM; Koropchak CM
    J Clin Microbiol; 1980 Sep; 12(3):367-74. PubMed ID: 6260833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Complement fixing antibody to varicella-zoster virus in different age groups and after zoster.
    Moschen ME; Peserico A; Trivello R
    Boll Ist Sieroter Milan; 1977 Mar; 56(1):70-3. PubMed ID: 193530
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies against varicella-zoster virus and herpes simplex virus deoxythymidine kinase in heterologous infections.
    Källander CF; Torfason EG; Olding-Stenkvist E; Sundqvist VA; Diderholm H; Gronowitz JS
    J Med Virol; 1989 May; 28(1):30-7. PubMed ID: 2542443
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serology indicates cytomegalovirus infection is associated with varicella-zoster virus reactivation.
    Ogunjimi B; Theeten H; Hens N; Beutels P
    J Med Virol; 2014 May; 86(5):812-9. PubMed ID: 24037981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between preexisting anti-varicella-zoster virus (VZV) antibody and clinical VZV reactivation in hematopoietic stem cell transplantation recipients.
    Onozawa M; Hashino S; Takahata M; Fujisawa F; Kawamura T; Nakagawa M; Kahata K; Kondo T; Ota S; Tanaka J; Imamura M; Asaka M
    J Clin Microbiol; 2006 Dec; 44(12):4441-3. PubMed ID: 17035500
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reactivity of varicella-zoster virus subunit antigens in enzyme-linked immunosorbent assay to sera from varicella, zoster, and herpes simplex virus infections.
    Takayama M
    Med Microbiol Immunol; 1994 Feb; 183(1):1-11. PubMed ID: 8202026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Skin test with Varicella-zoster virus antigen on herpes zoster patients.
    Hata S
    Arch Dermatol Res; 1980; 268(1):65-70. PubMed ID: 6251751
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific immunoglobulin responses after varicella and herpes zoster.
    Cradock-Watson JE; Ridehalgh MK; Bourne MS
    J Hyg (Lond); 1979 Apr; 82(2):319-36. PubMed ID: 219110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neutralizing antibody responses to varicella-zoster virus.
    Schmidt NJ; Lennette EH
    Infect Immun; 1975 Sep; 12(3):606-13. PubMed ID: 170206
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody assays for varicella-zoster virus: comparison of enzyme immunoassay with neutralization, immune adherence hemagglutination, and complement fixation.
    Forghani B; Schmidt NJ; Dennis J
    J Clin Microbiol; 1978 Nov; 8(5):545-52. PubMed ID: 215602
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Varicella zoster antibody titers after the administration of intravenous immune serum globulin or varicella zoster immune globulin.
    Paryani SG; Arvin AM; Koropchak CM; Wittek AE; Amylon MD; Dobkin MB; Budinger MD
    Am J Med; 1984 Mar; 76(3A):124-7. PubMed ID: 6324585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Longitudinal analysis of varicella-zoster virus-specific antibodies in systemic lupus erythematosus: No association with subclinical viral reactivations or lupus disease activity.
    Rondaan C; van Leer CC; van Assen S; Bootsma H; de Leeuw K; Arends S; Bos NA; Westra J
    Lupus; 2018 Jul; 27(8):1271-1278. PubMed ID: 29667858
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should patients with zoster receive zoster immune globulin?
    Uduman SA; Gershon AA; Brunell PA
    JAMA; 1975 Dec; 234(10):1049-51. PubMed ID: 171458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The etiologic agents of varicella and herpes zoster; serologic studies with the viruses as propagated in vitro.
    WELLER TH; WITTON HM
    J Exp Med; 1958 Dec; 108(6):869-90. PubMed ID: 13598817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of acyclovir and prednisolone on the serological response in herpes zoster.
    Bates CJ; Kudesia G; McKendrick MW
    J Med Virol; 1996 Nov; 50(3):244-8. PubMed ID: 8923289
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibody responses to early antigens of varicella-zoster virus (VZV) during varicella and zoster.
    Namazue J; Kato T; Yamanishi K; Takahashi M; Asano Y; Muraki R
    Biken J; 1986 Dec; 29(3-4):91-7. PubMed ID: 3039973
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allotype analysis to distinguish the origin of varicella-zoster virus immunoglobulin G after allogeneic stem cell transplantation.
    Yamazaki R; Nakasone H; Tanaka Y; Sato M; Terasako K; Wada H; Ishihara Y; Kawamura K; Sakamoto K; Ashizawa M; Machishima T; Kimura S; Kikuchi M; Okuda S; Kako S; Kanda J; Tanihara A; Nishida J; Kanda Y
    Biol Blood Marrow Transplant; 2013 Jul; 19(7):1013-20. PubMed ID: 23583826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.